Skip to main content
Journal cover image

Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome.

Publication ,  Journal Article
O'Connor, A; Gill, S; Neary, E; White, S; Ford, AC
Published in: Aliment Pharmacol Ther
October 11, 2024

BACKGROUND: Anxiety and depression are associated strongly with irritable bowel syndrome (IBS). Dietary therapies are used increasingly in the management of IBS, but the impact of common mental disorders on response to these has not been well studied. AIMS: To examine whether symptoms compatible with common mental disorders influence response to dietary interventions. METHODS: Prospective cohort study of adults, with either diarrhoea-predominant or mixed bowel habits, IBS Severity Scoring System [IBS-SSS] score ≥ 75 points. Participants completed the Hospital Anxiety and Depression score (HADS) and attended initially for British Dietary Association advice for IBS. IBS-SSS was re-checked 3 months later to assess response. If primary endpoint (≥ 50 point decrease in IBS-SSS) was not achieved, patients were offered low fermentable oligo-, di- and monosaccharides and polyol diet and repeated IBS-SSS after another 3 months. Secondary endpoints included of change in IBS-SSS and effect of symptom severity on response. RESULTS: In total, 448 patients took part, average age of 42 years and 79.0% were female. 69.9% of participants had HADS-A scores ≥ 8 and 39.3% with HADS-D scores ≥ 8. Average IBS-SSS score at baseline was 290 (SD 86). No significant difference was noted in achievement of the primary endpoint according to HADS-A scores (53.4% vs. 62.2% by ITT in those with HADS-A ≥ 8 vs. HADS-A < 8, p = 0.09). Patients with HADS-D ≥ 8 were significantly less likely to achieve the primary endpoint compared with those with HADS-D < 8 (43.8% vs. 64.0% by ITT, p < 0.01). CONCLUSION: Understanding psychological profile of patients can help predicting their response to IBS dietary interventions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Aliment Pharmacol Ther

DOI

EISSN

1365-2036

Publication Date

October 11, 2024

Location

England

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
O’Connor, A., Gill, S., Neary, E., White, S., & Ford, A. C. (2024). Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome. Aliment Pharmacol Ther. https://doi.org/10.1111/apt.18337
O’Connor, Anthony, Sarah Gill, Elaine Neary, Sarah White, and Alexander C. Ford. “Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome.Aliment Pharmacol Ther, October 11, 2024. https://doi.org/10.1111/apt.18337.
O’Connor A, Gill S, Neary E, White S, Ford AC. Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome. Aliment Pharmacol Ther. 2024 Oct 11;
O’Connor, Anthony, et al. “Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome.Aliment Pharmacol Ther, Oct. 2024. Pubmed, doi:10.1111/apt.18337.
O’Connor A, Gill S, Neary E, White S, Ford AC. Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome. Aliment Pharmacol Ther. 2024 Oct 11;
Journal cover image

Published In

Aliment Pharmacol Ther

DOI

EISSN

1365-2036

Publication Date

October 11, 2024

Location

England

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences